2 years ago
SRPT
AnalystsBiren AminBiren Amin's Stock Forecasts
AnalystsBiren Amin
Analyst Ranking
Bottom 3%
#5402 out of 5548 analysts
Average Return
-10.33%
Win Rate
38%31 out of 82
Risk vs Reward
Poor
Good
Biren Amin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aclaris Therapeutics IncACRS | +259.12% | $1.59 | $5.71 | 2025-07-10 - 2026-07-09 | Strong Buy |
Solid Biosciences IncSLDB | +149.82% | $2.77 | $6.92 | 2025-05-16 - 2026-05-15 | Strong Buy |
Allogene Therapeutics IncALLO | +144.49% | $0.95 | $2.33 | 2025-05-14 - 2026-05-13 | Strong Buy |
Neurocrine Biosciences IncNBIX | +92.27% | $61.94 | $119.09 | 2017-10-03 - 2018-10-03 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +91.79% | $14.38 | $27.58 | 2025-03-31 - 2026-03-30 | Strong Buy |
Biren Amin Analyst Color
Get additional color on Biren Amin's coverage of popular stocks
Biren Amin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 5 | Strong Buy | $865.00 | +7.45% | Maintains | 6 days ago |
Lenz Therapeutics IncLENZ | 5 | Hold | $5.00 | +58.23% | Maintains | 6 days ago |
Bridgebio Pharma IncBBIO | 6 | Strong Buy | $120.00 | +75.03% | Maintains | 6 days ago |
Minerva Neurosciences IncNERV | 5 | Strong Buy | $10.00 | +334.78% | Upgrades | 2 months ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $2.00 | +292.16% | Initiates Coverage On | 2 months ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $14.00 | +769.57% | Maintains | 2 months ago |
Compass Therapeutics IncCMPX | 2 | Strong Buy | $6.00 | +688.44% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 13 | Hold | $20.00 | +12.80% | Maintains | 4 months ago |
Connect Biopharma Holdings LtdCNTB | 1 | Strong Buy | $7.00 | +813.84% | Initiates Coverage On | 4 months ago |
Solid Biosciences IncSLDB | 3 | Strong Buy | $18.00 | +204.05% | Maintains | 5 months ago |
Aclaris Therapeutics IncACRS | 2 | Strong Buy | $11.00 | +193.33% | Maintains | 6 months ago |
Context Therapeutics IncCNTX | 2 | Strong Buy | $7.00 | +2,828.87% | Maintains | 7 months ago |
Immatics NvIMTX | 2 | Strong Buy | $18.00 | +146.24% | Assumes | 7 months ago |
Allogene Therapeutics IncALLO | 4 | Strong Buy | $8.00 | +540.00% | Maintains | 7 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $140.00 | +26.40% | Maintains | 8 months ago |
Okyo Pharma LtdOKYO | 1 | Strong Buy | $7.00 | +400.00% | Initiates Coverage On | 8 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $7.00 | +101.73% | Initiates Coverage On | a year ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $48.00 | +210.88% | Initiates Coverage On | a year ago |
Ocular Therapeutix IncOCUL | 2 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $95.00 | N/A | Maintains | a year ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Elevation Oncology IncELEV | 2 | Hold | $0.70 | N/A | Downgrades | 2 years ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $71.00 | N/A | Maintains | 2 years ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Immunome IncIMNM | 3 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 2 | Strong Buy | $115.00 | N/A | Maintains | 2 years ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $32.00 | N/A | Maintains | 2 years ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $70.00 | N/A | Maintains | 3 years ago |
Irulya Therapeutics IncIRLA | 2 | Hold | $34.00 | N/A | Downgrades | 6 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $2,550.00 | N/A | Initiates Coverage On | 6 years ago |
Urovant Sciences LtdUROV | 1 | Hold | $16.25 | N/A | Downgrades | 6 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 6 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 6 years ago |
Kala Bio IncKALA | 2 | Hold | $25,000.00 | N/A | Downgrades | 6 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Strong Buy | $54.00 | N/A | Initiates Coverage On | 6 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | $10.00 | N/A | Downgrades | 6 years ago |
Calithera Biosciences IncCALA | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 7 years ago |
Synthorx IncTHOR2 | 1 | Hold | $68.00 | N/A | Downgrades | 7 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Hold | $2,400.00 | N/A | Downgrades | 8 years ago |
Armo Biosciences IncARMO | 1 | Hold | $50.00 | N/A | Downgrades | 8 years ago |
Bluebird Bio IncBLUE | 4 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $101.00 | N/A | Initiates Coverage On | 9 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $69.00 | N/A | Maintains | 9 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $155.00 | N/A | Initiates Coverage On | 9 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 10 years ago |
Obseva SaOBSVF | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.